Skyrizi (150 MG Dose) and Valproate sodium Intravenous
Determining the interaction of Skyrizi (150 MG Dose) and Valproate sodium Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproate sodium (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Skyrizi (150 MG Dose)-Valproic acid
- Skyrizi (150 MG Dose)-Valproic Acid and Derivatives
- Skyrizi (150 MG Dose)-Valproic Acid Capsules
- Skyrizi (150 MG Dose)-Valproic Acid Liquid
- Skyrizi (150 MG Dose)-Valproic Acid Oral Solution
- Skyrizi (150 MG Dose)-Valproic Acid Syrup
- Valproate sodium Intravenous-Skyrizi Injection
- Valproate sodium Intravenous-Skyrizi topical
- Valproate sodium Intravenous-Sleep Aid
- Valproate sodium Intravenous-Sleep Aid Tablets
- Valproate sodium Intravenous-Sleepinal
- Valproate sodium Intravenous-Slo-Niacin